Basics NewAmsterdam Pharma Company IPO Date: February 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $3.04B Activated in VL: True Average Daily Range Avg Daily Range: $0.44 | 2.73% Avg Daily Range (30 D): $0.59 | 2.46% Avg Daily Range (90 D): $0.54 | 2.58% Institutional Daily Volume Avg Daily Volume: .33M Avg Daily Volume (30 D): .7M Avg Daily Volume (90 D): .72M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 81 Avg Trade Size (Sh.) (90 D): 86 Institutional Trades Total Inst.Trades: 680 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.33M Avg Inst. Trade (90 D): $1.36M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.26M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.23M Avg Closing Volume: 58.99K     News Aug 7, 2025 @ 12:21 AM NewAmsterdam (NAMS) Q2 Revenue Jumps 49% Source: Jesterai Jun 9, 2025 @ 11:00 AM NewAmsterdam Pharma Announces Positive Topline Alz... Source: N/A Jan 9, 2025 @ 8:38 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: N/A Dec 13, 2024 @ 10:16 PM NewAmsterdam Pharma Announces Closing of Upsized $... Source: N/A Dec 12, 2024 @ 2:37 AM NewAmsterdam Pharma Announces Pricing of Upsized $... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.62 $-.15 $-.34 Diluted EPS $-1.62 $-.15 $-.34 Revenue $ 64.01M $ 19.15M $ 2.98M Gross Profit $ $ $ Net Income / Loss $ -165.72M $ -17.36M $ -39.53M Operating Income / Loss $ -172.79M $ -35.64M $ -68.93M Cost of Revenue $ $ $ Net Cash Flow $ 123.96M $ -193.38M $ -27.09M PE Ratio